Given that BA activation may exert a protective effect on tumors [48], we hypothesize that elevated SERPINB5 expression in PAAD may indirectly interfere with BA activation and its antitumor function by modulating the local inflammatory environment of the tumor, thus promoting PAAD progression. The gene discussed is SERPINB5; the disease is neoplasm.